NCT00554450View on ClinicalTrials.gov

Renal Impairment in Type 2 Diabetic Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Dapagliflozin

Tablets, Oral, once daily

Trial Locations (4)

33169

Elite Research Institute, Miami

55114

Prism Research, Saint Paul

78229

Dgd Research, Inc., San Antonio

92801

Advanced Clinical Research Institute, Anaheim

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY